Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The sensitivity of the GLP-1 hormone, which is secreted by the gastrointestinal tract, can predict the metabolic efficacy of a gastric bypass.
The use of a GLP1 challenge could thus function as a novel predictive biomarker for personalized treatment of type 2 diabetes and obesity. These findings were reported by scientists of Helmholtz Zentrum M?nchen and the University of Cincinnati, Ohio, USA in the current issue of the journal Diabetes.
The gastric bypass is one of the most commonly performed surgical procedures in the treatment of obesity. In most patients, it quickly produces substantial body weight loss. Moreover, even before the weight loss, the procedure leads to improved glucose tolerance. However, these metabolic improvements vary considerably from patient to patient.
http://yottafire.com/2013/12/gut-hormone-test-predicts-individual-efficacy-gastric-bypass/
The use of a GLP1 challenge could thus function as a novel predictive biomarker for personalized treatment of type 2 diabetes and obesity. These findings were reported by scientists of Helmholtz Zentrum M?nchen and the University of Cincinnati, Ohio, USA in the current issue of the journal Diabetes.
The gastric bypass is one of the most commonly performed surgical procedures in the treatment of obesity. In most patients, it quickly produces substantial body weight loss. Moreover, even before the weight loss, the procedure leads to improved glucose tolerance. However, these metabolic improvements vary considerably from patient to patient.
http://yottafire.com/2013/12/gut-hormone-test-predicts-individual-efficacy-gastric-bypass/